
GKB Ophthalmics Ltd is Rated Strong Sell
2026-05-13 10:11:11GKB Ophthalmics Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 10 Dec 2024. However, the analysis and financial metrics discussed here reflect the stock's current position as of 13 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read More
GKB Ophthalmics Ltd is Rated Strong Sell
2026-04-30 10:11:00GKB Ophthalmics Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 10 December 2024. However, the analysis and financial metrics discussed here reflect the stock's current position as of 30 April 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.
Read More
GKB Ophthalmics Ltd is Rated Strong Sell
2026-04-10 10:10:57GKB Ophthalmics Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 10 Dec 2024, reflecting a shift from the previous 'Sell' grade. However, the analysis and financial metrics discussed here represent the stock's current position as of 10 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.
Read MoreAnnouncement under Regulation 30 (LODR)-Newspaper Publication
01-Jun-2026 | Source : BSEPlease find enclosed copies of newspaper cuttings of the extract of statement of audited Standalone and Consolidated Financial Results for the year ended March 31 2026 published in Free Press Journal (Mumbai Edition) and on Pudhari (Marathi) dated May 29 2026. Please acknowledge receipt.
Compliances-Reg.24(A)-Annual Secretarial Compliance
23-May-2026 | Source : BSEPursuant to Regulation 24A of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 enclosed please find the Annual Secretarial Compliance Report for the year ended March 31 2026 issued by Ms. Girija Nagvekar Practicing Company Secretary and Secretarial Auditor of the Company. Kindly take the above information on record.
Board Meeting Intimation for Approval Of Audited Financial Results For The Quarter And Year Ende March 31 2026.
04-May-2026 | Source : BSEGKB Ophthalmics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2026 inter alia to consider and approve the Audited Standalone and Consolidated Financial Results of the company for the qurter and year ended March 31 2026. The Notice can be accessed at the Companys website at www.gkb.net Further notice is hereby given with reference to the above meeting of the Board of Directors that the Trading Window for dealing with equity shares of the Company by designated persons under the SEBI (Prohibition of Insider Trading) Regulation 2015 had been closed from April 01 2026 will now re-open after the completion of 48 hours from the date of submission of financial results to the Stock Exchange. This communication has been sent to all the Directors sand all the designated emplyoyees of the Company.
Corporate Actions
No Upcoming Board Meetings
GKB Ophthalmics Ltd has declared 12% dividend, ex-date: 21 Sep 10
No Splits history available
No Bonus history available
No Rights history available